The global health burden of infection‐associated cancers in the year 2002

International Journal of Cancer - Tập 118 Số 12 - Trang 3030-3044 - 2006
Donald Maxwell Parkin1
1Clinical Trials Service Unit and Epidemiological Studies Unit, University of Oxford, Headington, UK. [email protected]

Tóm tắt

Abstract

Several infectious agents are considered to be causes of cancer in humans. The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas. The estimated total of infection‐attributable cancer in the year 2002 is 1.9 million cases, or 17.8% of the global cancer burden. The principal agents are the bacterium Helicobacter pylori (5.5% of all cancer), the human papilloma viruses (5.2%), the hepatitis B and C viruses (4.9%), Epstein‐Barr virus (1%), human immunodeficiency virus (HIV) together with the human herpes virus 8 (0.9%). Relatively less important causes of cancer are the schistosomes (0.1%), human T‐cell lymphotropic virus type I (0.03%) and the liver flukes (0.02%). There would be 26.3% fewer cancers in developing countries (1.5 million cases per year) and 7.7% in developed countries (390,000 cases) if these infectious diseases were prevented. The attributable fraction at the specific sites varies from 100% of cervix cancers attributable to the papilloma viruses to a tiny proportion (0.4%) of liver cancers (worldwide) caused by liver flukes. © 2006 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

Parkin DM, 1999, 5

Ferlay J, 2004, GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide

Mueller NE, 2005, Cancer epidemiology and prevention

Parkin DM, 2002

10.1093/jnci/92.22.1823

Ries LAG, 2004, SEER cancer statistics review, 1975–2001

UNAIDS 2004 Country‐specific HIV and AIDS estimates and data end 2003 (UNAIDS July 2004).http://www.unaids.org/epidemic_update/report/index.html.

10.1002/cncr.20622

Cole P, 1971, Attributable risk percent in case‐control studies, Brit J Prev Soc Med, 25, 242

10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

1994, Schistosomes, liver flukes and helicobacter pylori

Mégraud F, 1989, Seroepidemiology of Campylobacter pylori infection in various populations, J Clin Microbiol, 27, 1870, 10.1128/jcm.27.8.1870-1873.1989

10.1016/0140-6736(93)90938-D

10.1136/gut.49.3.347

Everhart JE, 2002, Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clinics of, N America, 29, 559

10.1093/oxfordjournals.epirev.a018040

10.1046/j.1365-2036.2002.0160s1003.x

Wang KJ, 2003, [Meta‐analysis on the epidemiology of Helicobacter pylori infection in China], Zhonghua Liu Xing Bing Xue Za Zhi, 24, 443

10.3322/canjclin.55.2.74

10.1016/S0016-5085(98)70422-6

10.1111/j.1572-0241.1999.01360.x

10.1046/j.1365-2036.1999.00546.x

10.1093/jnci/91.9.786

10.1056/NEJM199405053301803

10.1002/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R

2005, Human papillomaviruses

10.1006/gyno.2001.6502

10.1093/jnci/89.20.1516

Herrero R, 1999, Cancer surveys, 75

10.1016/0029-7844(95)00351-7

Frisch M, 1999, Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses, Cancer Res, 59, 753

10.1097/00000478-200105000-00017

10.1016/S0002-9440(10)62506-0

10.1093/jnci/90.21.1585

Franceschi S, 1996, Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence, Cancer Epidemiol Biomarkers Prev, 5, 567

10.1016/S0738-081X(96)00156-3

10.1097/00001622-200105000-00009

10.1093/jnci/djg107

10.1002/ijc.1313

1994, Hepatitis Viruses

10.1097/00004836-200411003-00008

10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2

10.1038/sj.bjc.6602333

10.1023/A:1008951901148

10.1093/aje/kwg041

10.1002/hep.20027

WHO:hepatitis C‐Global prevalence (update). Weekly Epidemiological Record No 49 Dec1999.425–7.

10.1016/S1473-3099(02)00264-5

Walter SD, 1983, Effects of interactions, confounding and observational error on attributable risk estimation, Amer J Epidemiol, 171, 598, 10.1093/oxfordjournals.aje.a113582

1997, Infections with Epstein‐Barr virus and human herpes viruses

10.1038/274756a0

10.1016/S0065-230X(08)60470-4

10.1016/1047-2797(90)90020-S

Lenoir GM, 1984, 283

10.1182/blood.V79.12.3261.3261

10.1111/j.1365-2613.2001.iep190.x

10.1002/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X

10.1002/ijc.2910340203

10.1056/NEJM198903163201103

10.1056/NEJM198902233200806

Armstrong AA, 1992, Criteria for the definition of Epstein‐Barr virus association in Hodgkin's disease, Leukemia, 6, 869

10.1136/adc.74.1.27

10.1136/jcp.44.10.844

10.1038/bjc.1991.281

10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T

10.1016/S1044579X02000858

10.1002/ijc.2910160503

10.1002/jmv.1890270403

10.3109/02841869409098448

10.1056/NEJMoa011610

Pathmanathan R, 1995, Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein‐Barr virus‐infected neoplasia, Am J Pathol, 146, 1355

1996, Human immunodeficiency viruses and human T‐cell lymphotropic viruses

Centers for Disease Control, 1992, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, Morb Mortal Wkly Rep, 41, 1

10.1016/S0140-6736(97)09028-4

10.1001/jama.285.13.1736

10.1097/00002030-200205240-00009

10.1098/rstb.2000.0778

10.1038/sj.bjc.6690782

10.1016/S0168-1702(01)00394-X

Oettlé AG, 1962, Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes, Acta Unio Int Contra Cancrum, 18, 330

Templeton AC, 1981, Pathology annual, 315

10.1002/(SICI)1097-0142(19970301)79:5<1004::AID-CNCR17>3.0.CO;2-5

10.1016/0140-6736(90)90001-L

10.1002/ijc.2910470110

10.1093/oxfordjournals.aje.a116855

Lundgren JD, 1995, Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow‐up, Am J Epidemiol, 141, 652, 10.1093/oxfordjournals.aje.a117481

Wabinga HR, 2000, Trends in cancer incidence in Kyandondo County, Uganda, 1969–1977, Brit J Cancer, 82, 1585

10.1097/00002030-199912240-00012

10.1056/NEJM198402233100804

10.1016/S0140-6736(84)90241-1

10.1016/S0140-6736(84)90240-X

10.1002/ijc.2910540106

10.1016/S0140-6736(82)92740-4

10.1016/0140-6736(91)92513-2

Serraino D, 1992, Epidemiology of acquired immunodeficiency syndrome and associated tumor in Europe, Ann Oncol, 3, 595, 10.1093/oxfordjournals.annonc.a058283

10.1016/S0140-6736(95)92583-X

10.1038/bjc.1997.290

10.1002/1097-0215(20001101)88:3<489::AID-IJC25>3.0.CO;2-Q

10.1097/00002030-200012220-00015

Mbulaiteye SM, 2005, Spectrum of cancers among HIV‐infected persons in Africa: The Uganda AIDS‐Cancer Match Registry Study, Int J Cancer

10.1002/ijc.2910590106

Hamilton‐Dutoit SJ, 1993, In situ demonstration of Epstein‐Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome‐related lymphomas: correlation with tumor morphology and primary site, Blood, 82, 619, 10.1182/blood.V82.2.619.619

10.1016/S0959-8049(01)00120-4

10.1093/jnci/92.18.1500

Parkin DM, 2003, Cancer in Africa: epidemiology and prevention

10.1016/S0140-6736(95)91309-2

Mustacchi P, 1958, Cancer of the bladder and infestation with Schistosoma haematobium, J Natl Cancer Inst, 20, 825

10.1016/S0140-6736(67)92714-6

10.1111/j.1464-410X.1983.tb03297.x

10.1007/BF01831379

10.1038/bjc.1998.197

Utroska JA, 1989, An estimate of global needs for praziquantel within Schistosomiasis control programmes

Uchiyama T, 1977, Adult cell leukaemia: clinical and hematologic features of 16 cases, Blood, 50, 481, 10.1182/blood.V50.3.481.481

Yoshida M, 1985

10.1007/978-3-642-70113-9_11

10.1093/infdis/147.3.406

Tajima K, 1992, Epidemiology of HTLV I/II in Japan and the world. Gann monograph on cancer research (Japanese), J Cancer Res, 39, 129

Verdier M, 1984, AIDS in Africa, 173

10.1002/ijc.2910430618

Tajima K, 1985, Estimation of incidence rate of ATL among ATLV carriers in Kyushu, Japan (Japanese), J Clin Oncol, 15, 423

Tokudome S, 1989, Incidence of adult T‐cell leukaemia/lymphoma among human T‐lymphotropic virus type I carriers in Saga (Japanese), Cancer Res, 49, 226

10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B

10.1002/ijc.2910430214

10.1093/jnci/87.13.1009

Levine PH, 1992, The epidemiology of human virus associated haematologic maligancies, Leukemia, 6, 54S

10.1002/ijc.2910480302

10.1002/ijc.2910590412

10.1002/ijc.21146

Chung CS, 1976, An epidemiological study of primary liver carcinomas in Pusan area with special reference to clonorchiasis (Korean), J Pathology, 10, 33

10.1093/ije/25.5.933

Parkin DM, 1993, Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention, Cancer Epidemiol Biomarkers Prev, 2, 537

1995, WHO Control of Food borne trematode infections

10.1002/path.1296

10.1136/mp.53.5.255

10.1002/ijc.2910600513

10.1053/j.gastro.2003.09.025

10.1002/ijc.20205

10.1002/ijc.20257

10.1056/NEJM199007123230202

10.1093/aje/kwh039

The Gambia Hepatitis Study Group, 1987, The Gambia Hepatitis Intervention Study (GHIS), Cancer Res, 47, 5782

Sun Z, 1991, Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5‐year results of its pilot study, Cancer Detect Prev, 15, 313

World Health Organization (WHO).Immunization surveillance assessment and monitoring.http://www.who.int/immunization_monitoring/en/(Accessed October 2005).

10.1056/NEJM199706263362602

10.1056/NEJMoa020586

10.1016/S0140-6736(04)17398-4

10.1016/S1470-2045(05)70101-7

SkjeldestadFE.Prophylactic quadrivalent human papillomavirus (HPV) (types 6 11 16 18) L1 virus‐like particle (VLP) vaccine (Gardasil(tm)) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk. Presented at the 2005 meeting of the Infectious Diseases Society of America. San Francisco CA. Abstract LB‐8a.

10.1002/ijc.20244

10.1016/S0140-6736(96)01501-2

10.1046/j.1365-2036.2002.01204.x

10.1001/jama.291.2.187

10.1001/jama.291.2.244

United Nations(2003)World population prospects. The 2002 revision. Population database.http://esa.un.org/unpp/.